Methenamine Hippurate Tablet
Product Images NDC 60687-694

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Methenamine Hippurate (NDC 60687-694). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ahp69421

FDA Label Image

1 G Methenamine Hippurate Tablet Blister (Blister)

This appears to be a list of pharmaceutical products containing Methenamine Hippurate and/or Wethenamine Hippurate, which are both used to treat urinary tract infections. The list includes different variations of the medications and some alphanumeric codes, but there is not enough information to provide a more detailed description.*

FDA Label Image

1 G Methenamine Hippurate Tablets Carton (Carton)

Methenamine Hippurate is a drug available in the form of tablets with NDC code 60667-694-21 and 60687-694-21. These tablets are Rx only containing 30 tablets, with usual dosage mentioned in the package insert. Storage instructions are mentioned on the pack, and it is advised to keep all drugs out of children's reach. The manufacturer of the product is KBC's 12571532, Hicio Labs USA, and it is distributed by American Health Packaging, Columbus, Ohio. The given text provides all essential information required for the drug.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.